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T I M E ( s e c )
Timing of events leading to radiation effects. 
w R is the radiation weighting factor, which accounts for the detriment caused by different types of radiation relative to photon irradiation D T,R is the absorbed dose averaged over the tissue T due to radiation R w R values are derived from in vivo and in vitro RBE studies They are independent of dose and dose rate in the low dose region 
Deterministic Effects
Radiation effects for which generally a threshold level of dose exists above which the severity of the effect is greater for a higher dose.
Stochastic Effects
Radiation effects, generally occurring without a threshold level of dose, whose probability is proportional to the dose and whose severity is independent of the dose. ▲ A-bomb data -statistically significant dose-related incidence.
▲ Chernobyl -some evidence in the Russian study on emergency workers for a doserelated increase. From current evidence, a judgement can be made of a threshold acute dose of about 0.5 Gy (or 500 mSv) for both cardiovascular disease and cerebrovascular disease. On that basis, 0.5 Gy may lead to approximately 1% of exposed individuals developing the disease in question, more than 10 years after exposure. This is in addition to the high natural incidence (circulatory diseases account for 30-50% of all deaths in most developed countries). 
